Synthes and Lilly Sign Development and Collaboration... ( WEST CHESTER Pa. and INDIANAPOLIS Jun...)

Synthes and Lilly Sign Development and Collaboration Agreement

Date:6/9/2011

WEST CHESTER, Pa. and INDIANAPOLIS, June 9, 2011 /PRNewswire/ -- Synthes, Inc. (SIX: SYST.VX) and Eli Lilly and Company (NYSE: LLY) today announced the signing of an exclusive worldwide collaboration agreement to address the needs of patients who are cared for by orthopedic surgeons, including those with osteoporosis and those with bone fractures.

The agreement allows for the joint development and licensing of early stage compounds from Lilly to Synthes for use within orthopedic trauma, spine, craniomaxillofacial and reconstructive areas. These compounds have pre-clinical and in some cases clinical data packages and have the potential to aid in the local treatment and regeneration of the skeleton. The two companies will jointly develop site-specific osteoinductive (i.e. bone healing) products based on Synthes' biomaterials combined with Lilly's biologics or pharmaceuticals.

Within a second development program, Synthes and Lilly will jointly conduct and fund the evaluation of additional orthopedic uses for Lilly's osteoporosis drug Forteo® (teriparatide [rDNA origin] injection), marketed as Forsteo® in some countries outside of the United States). Building upon a Phase II study that Lilly has already completed, Lilly and Synthes will collaborate on additional clinical studies to evaluate potential future indications for Forteo, including fracture healing.

In addition to the development component of the agreement, the collaboration also includes the U.S. co-promotion of Forteo to orthopedic surgeons, an important segment of physicians who treat patients with a fracture due to osteoporosis. The companies will also co-promote Forteo in select countries and regions outside of the United States.

"I am very excited about this unique collaboration that will utilize the complementary clinical, development and operati
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8
Related medicine technology :

1. BGI Releases a Complete De Novo E. Coli O104 Genome Assembly and is Making Its Detection Kit Protocols and Synthesized Primers Freely Available to Worldwide Disease Control and Research Agencies
2. Johnson & Johnson and Synthes Announce Definitive Merger Agreement to Create Worlds Most Innovative and Comprehensive Orthopaedics Business
3. Hologics Selenia Dimensions (3-D) Digital Mammography Tomosynthesis System Receives Favorable Votes From FDA Advisory Panel
4. Cambrex Continuous-Flow Microwave-Assisted Organic Synthesis Technology Wins 2009 Silver Innovation Award
5. U.S. District Court Rules in Favor of Lilly in Amylin Litigation
6. FDA Approves Updates to Lillys Humalog® (insulin lispro injection [rDNA origin]) Label
7. Correction: Lilly Presents Data on Cixutumumab in Five Subtypes of Sarcomas
8. Amylin Pharmaceuticals Obtains Temporary Restraining Order Against Eli Lilly
9. Lilly Comments on Court Ruling in Amylin Litigation
10. Lilly and Investor Group Form New Critical Care Company BioCritica, Sign Xigris License Agreement
11. Study Determined Best Dose and Showed 55 Percent Response Rate With Lilly Anti-BAFF Monoclonal Antibody in Previously-Treated Multiple Myeloma Patients

Post Your Comments:

(Date:5/24/2013)... 24, 2013 In accordance with Rule 17.1 and ... of the United States Exchange Act, Echo Pharma Acquisition Limited ... Elan Corporation (NYSE: ELN). Background On ... an offer for the entire of the issued and to ... "Original Offer"). On 20 May 2013, Royalty ...

(Date:5/24/2013)... WELWYN GARDEN CITY, England and ... Heptares Therapeutics, the leading GPCR drug discovery and development company, ... Akira Usui as a Consultant to augment the Company,s ... Asian territories. Mr Usui has more than 15 years ... pharmaceutical industry including senior roles at Perlegen Sciences, Inc., Roche Pharma ...

(Date:5/23/2013)... y PARÍS, 24 de mayo de 2013 /PRNewswire/ ... destacado desarrollador y fabricante de herramientas de precisión ... y tratamiento de la enfermedad vascular periférica y ... ADVISE ( Ad enosine V asodilator ... II durante la sesión de ensayo clínico hot ...

Breaking Medicine Technology:Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 2 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 3 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 4 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 5 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 6 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 7 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 8 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 9 Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6

[0] Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements [0] Heptares Augments Business Development Capabilities in Japan and Other Asian Territories [0] Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2

... an icon of scientific skincare development, continues to provide award ... Kinerase Restructure Firming Eye Cream has ... Beauty Awards, appearing in the magazine,s October 2011 issue. ... over 236 beauty products were chosen as winners across a ...

... WOODLANDS, Texas, Sept. 27, 2011 In today,s ... provide excellent, efficient care while ensuring the ongoing ... Specialty Health , a division of McKesson ... Select Program , it is now offering Innovative ...

Cached Medicine Technology:Kinerase Wins Allure Best of Beauty Award for 2nd Consecutive Year 2 New McKesson Specialty Health Program Helps Providers Thrive In Today's Quality-Driven Healthcare Environment 2 New McKesson Specialty Health Program Helps Providers Thrive In Today's Quality-Driven Healthcare Environment 3

Kinerase Wins Allure Best of Beauty Award for 2nd Consecutive Year New McKesson Specialty Health Program Helps Providers Thrive In Today's Quality-Driven Healthcare Environment

(Date:5/24/2013)... 2013 BestSatelliteProviders.com the online satellite ... of consumers compare the features and services offered ... recently released the rankings of the best ... for viewing on their website. , ... to Adam Matthews, the spokesperson for BestSatelliteProviders.com, “When ...

(Date:5/24/2013)... May 24 (HealthDay News) -- People with high levels ... to die of liver disease than those with lower ... of cadmium in urine is evidence of long-term exposure ... pollution and tobacco smoke, the Johns Hopkins researchers explained. ... that cadmium directly causes liver disease but instead suggest ...

(Date:5/24/2013)... May 24, 2013 6Webs.com has educated ... out a home security monitoring provider. The ... 6Webs.com the useful resource consumers prefer for unbiased and ... their evaluations of the leading wireless home security system ... are rated on a number of key factors including ...

(Date:5/24/2013)... According to a May 15, 2013 Time Online ... Spikes in Plastic Surgery Requests,” a number of ... facial plastic surgery and cosmetic improvements among people ... aware of the need to look good online and on ... even Skype's video chat feature (Go to goo.gl/WO0PR). , “According ...

(Date:5/24/2013)... CA (PRWEB) May 24, 2013 American ... care education community, proudly participated in festivities surrounding the ... 19-21. The event provided the perfect backdrop to introduce ... at 236 E. 3rd Street, housed in an architectural ... Building. , ACC was an active exhibitor throughout the ...

Breaking Medicine News(10 mins):Health News:Best Rural Internet Service Provider in 2013 by BestSatelliteProviders.com 2 Health News:High Cadmium Levels May Raise Risk for Dying From Liver Disease: Study 2 Health News:2013 Best Wireless Security System Providers Reported by 6Webs.com 2 Health News:Facebook and Google – Is Social Media Driving Demand for Plastic Surgery? 2 Health News:American Career College Revs Up Community Support During Toyota Grand Prix of Long Beach 2

[0] Best Rural Internet Service Provider in 2013 by BestSatelliteProviders.com [0] High Cadmium Levels May Raise Risk for Dying From Liver Disease: Study [0] 2013 Best Wireless Security System Providers Reported by 6Webs.com [0] Facebook and Google – Is Social Media Driving Demand for Plastic Surgery?[0] American Career College Revs Up Community Support During Toyota Grand Prix of Long Beach

... - Bikes for meetings, errands, exercise., - Reduce ... Field Museum will add,to its already extensive "green" record ... 2008 - just in time for spring., The ... encourages,employees to bicycle to work by providing showers and ...

... fat, fewer calories, lower sodium, and comparable ... taste in finished product containing SRB- ... major benefit-, PHOENIX, March 31 NutraCea (OTC Bulletin,Board: ... and technology, today released the results of a significant new,study, ...

... 31 LCA-Vision Inc. (Nasdaq:,LCAV), a leading provider ... announced the opening of its 76th LasikPlus(R) vision,center ... fourth,LasikPlus(R) vision center opened this year, and the ... opened a LasikPlus(R) vision,center in Paramus in April ...

... 31 Cardiac Science,Corporation (Nasdaq: CSCX ... diagnosis,resuscitation, rehabilitation, and informatics products, announced today ... that it completed,certification for its HeartCentrix(R) ECG ... is a leading developer and provider,of computer-based ...

... March 31 Streamline Health,Solutions, Inc. (Nasdaq: STRM ... and fiscal year ended January 31, 2008., Revenues ... $5.6 million, a,47% increase, compared with $3.8 million in ... for the fourth quarter was $781 thousand, a,153% increase, ...

... CITY, Calif., March 31 Ingenuity Systems, ... science researchers,announced today that Path Designer, the ... selected as the Best New Product by ... Medicine Tri-Conference in San Francisco. Path,Designer enables ...

Field Museum Launches Shared Bike Program for Employees NutraCea-Sponsored Study Demonstrates Benefits of Replacing Wheat Flour with Stabilized Rice Bran (SRB) in Battered and Fried Product Applications LCA-Vision Announces the Opening of its 76th LasikPlus(R) Vision Center in Woodbridge, New Jersey Cardiac Science Adds NextGen to Its Roster of Certified EMR System Partners Streamline Health Solutions, Inc. Reports Fourth Quarter and Fiscal Year 2007 Results Ingenuity's Path Designer is Selected as Best New Product by Life Science Community at 2008 Molecular Medicine Conference

Portable shields for your safety and convenience....

... Marshield manufactures standard and custom shields and barriers ... for low level or high level radiation shielding, ... 99.95% pure lead, lead acrylic, lead glass, lead ... materials. We can offer shielding from 1/32" thick ...

Full-Height Radiation Barriers provide full-body shielding and reduce eye strain during extended procedures....

Medicine Products:

Regular Barrier Porta-Shield MarShield's Lead Radiation Shields & Barriers Full-Height Radiation Barriers